Related Experiment Video
Updated: May 2, 2026
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
14.4K
Using comparative effectiveness research to remedy health disparities
Joel Kupersmith1, David LaBarca
1Georgetown University Medical Center, Washington, DC, USA. jk1688@georgetown.edu.
Journal of Comparative Effectiveness Research
|March 21, 2014
Summary
Comparative effectiveness research (CER) can address health disparities across biological, care, and social contexts. Integrating social and cultural research alongside healthcare improvements is crucial for equitable health outcomes.
Area of Science:
- Health disparities research
- Comparative effectiveness research (CER)
- Genomics and personalized medicine
Background:
- Health disparities represent a significant and ongoing challenge in research.
- Comparative effectiveness research (CER) offers a robust framework for evaluating interventions aimed at reducing these disparities.
Purpose of the Study:
- To classify comparative effectiveness research (CER) for health disparities at three scientific levels: basic biology, care and systems, and social and cultural context.
- To highlight the importance of social and cultural research in addressing health disparities.
Main Methods:
- Utilizing established research methodologies including randomized controlled trials (RCTs), database analysis, and observational/quasi-experimental designs.
- Employing advanced statistical techniques such as mixed methods and multilevel modeling.
- Incorporating community engagement and patient preferences into CER planning.
Main Results:
- Genomics holds potential for tailoring treatments to specific individuals and populations.
- Interventions in care and systems are vital for enhancing process and quality measures.
- Evidence suggests that solely improving healthcare processes may not fully resolve health disparities, underscoring the significance of social and cultural factors.
Conclusions:
- Addressing health disparities requires a multi-level approach encompassing basic biology, healthcare systems, and socio-cultural determinants.
- The integration of social and cultural research is paramount for achieving health equity.
- Community involvement and patient-centered approaches are essential for effective CER in disparities research.
More Related Videos
Related Concept Videos
01:25Strategies for Assessing and Addressing Confounding
596
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
419
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
419
01:20Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
01:26Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
01:12Hazard Ratio
756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
756